{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:26:13Z","timestamp":1769214373502,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.clim.2025.110645","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:08:42Z","timestamp":1764029322000},"page":"110645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Remaining molecular scarring in the skin of patients with psoriasis: What are the reversal factors?"],"prefix":"10.1016","volume":"283","author":[{"given":"Parvaneh","family":"Hatami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Nicknam Asl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab","family":"Aryanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azadeh","family":"Khayyat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Homayouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Mostaghimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2025.110645_bb0005","doi-asserted-by":"crossref","DOI":"10.1111\/jocd.15144","article-title":"Demographic and clinical characteristics of hospitalized psoriasis patients","author":"Aryanian","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.clim.2025.110645_bb0010","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1111\/jdv.13354","article-title":"European S3-guidelines on the systemic treatment of psoriasis vulgaris\u2013update 2015\u2013short version\u2013EDF in cooperation with EADV and IPC","volume":"29","author":"Nast","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"5","key":"10.1016\/j.clim.2025.110645_bb0015","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.3390\/ijms24054556","article-title":"Psoriatic resolved skin epidermal keratinocytes retain disease-residual transcriptomic and epigenomic profiles","volume":"24","author":"Ghaffarinia","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.clim.2025.110645_bb0020","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.3390\/jcm12206573","article-title":"The expression of activation markers CD25 and CD69 increases during biologic treatment of psoriasis","volume":"12","author":"Adamczyk","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.clim.2025.110645_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.crimmu.2023.100067","article-title":"Characteristics and sources of tissue-resident memory T cells in psoriasis relapse","volume":"4","author":"Dong","year":"2023","journal-title":"Curr. Res. Immunol."},{"key":"10.1016\/j.clim.2025.110645_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2025.102636","article-title":"Implication of epigenetic factors in development and recurrence of psoriasis","volume":"96","author":"Tang","year":"2025","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2025.110645_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2023.100211","article-title":"Paradoxical psoriasis: the flip side of idiopathic psoriasis or an autocephalous reversible drug reaction?","volume":"7","author":"Lu","year":"2023","journal-title":"J. Transl. Autoimmun."},{"issue":"4","key":"10.1016\/j.clim.2025.110645_bb0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.5114\/ada.2023.129322","article-title":"Does molecular scarring in psoriasis exist? A review of the literature","volume":"40","author":"Kasprowicz-Furma\u0144czyk","year":"2023","journal-title":"Postepy Dermatol. Alergol."},{"key":"10.1016\/j.clim.2025.110645_bb0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clim.2009.11.008","article-title":"Increased Th17 cells are accompanied by FoxP3+ Treg cell accumulation and correlated with psoriasis disease severity","volume":"135","author":"Zhang","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2025.110645_bb0050","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000238305","article-title":"Circulating CD4+CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients","volume":"219","author":"Quaglino","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.clim.2025.110645_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102453","article-title":"The pivotal role of CD69 in autoimmunity","volume":"111","author":"Gorabi","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2025.110645_bb0060","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jid.2016.04.032","article-title":"The Spectrum of mild to severe psoriasis vulgaris is defined by a common activation of IL-17 pathway genes, but with key differences in immune regulatory genes","volume":"136","author":"Kim","year":"2016","journal-title":"J. Invest. Dermatol."},{"issue":"17","key":"10.1016\/j.clim.2025.110645_bb0065","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.3390\/jcm10173822","article-title":"Skin-resident memory T cells: pathogenesis and implication for the treatment of psoriasis","volume":"10","author":"Vu","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.clim.2025.110645_bb0070","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1084\/jem.20031482","article-title":"Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-\u03b1","volume":"199","author":"Boyman o, Hefti HP, Conrad C, Nickoloff BJ, Suter m, Nestle fo.","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2025.110645_bb0075","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0002-9440(10)64410-0","article-title":"Direct evidence for interferon-\u03b3 production by effector-memory-type intraepidermal T cells residing at an effector site of immunopathology in fixed drug eruption","volume":"161","author":"Mizukawa","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"14","key":"10.1016\/j.clim.2025.110645_bb0080","article-title":"Crosstalk: keratinocytes and immune cells in psoriasis","volume":"9","author":"Kamata","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2025.110645_bb0085","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/ijms21020625","article-title":"Immunological memory of psoriatic lesions","volume":"21","author":"Owczarczyk Saczonek","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2025.110645_bb0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5114\/ada.2021.113125","article-title":"The effect of therapy on TRM in psoriatic lesions","volume":"39","author":"Owczarczyk-Saczonek","year":"2022","journal-title":"Adv. Dermatol. Allergol."},{"key":"10.1016\/j.clim.2025.110645_bb0095","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.jid.2018.02.030","article-title":"Resident T cells in resolved psoriasis steer tissue responses that stratify clinical outcome","volume":"138","author":"Gallais S\u00e9r\u00e9zal","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"24","key":"10.1016\/j.clim.2025.110645_bb0100","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1097\/CM9.0000000000001232","article-title":"Time to relapse after treatment withdrawal for different biologics used to treat plaque psoriasis","volume":"133","author":"Wang","year":"2020","journal-title":"Chin. Med. J."},{"issue":"21","key":"10.1016\/j.clim.2025.110645_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112849","article-title":"Could targeted pharmacotherapies exert a \u201cdisease modification effect\u201d in patients with chronic plaque psoriasis?","volume":"23","author":"Bellinato","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.clim.2025.110645_bb0110","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jid.2016.11.033","article-title":"Dynamic changes in resident and infiltrating epidermal dendritic cells in active and resolved psoriasis","volume":"137","author":"Martini","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.clim.2025.110645_bb0115","doi-asserted-by":"crossref","first-page":"7581","DOI":"10.1038\/s41467-025-62874-9","article-title":"CCR7+ dendritic cells expressing both IL-23A and IL-12B potentially contribute to psoriasis relapse","volume":"16","author":"Sun","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2025.110645_bb0120","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/exd.12190","article-title":"Reduction of inflammatory slan (6-sulfo LacNAc) dendritic cells in psoriatic skin of patients treated with etanercept","volume":"22","author":"G\u00fcnther","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.clim.2025.110645_bb0125","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1189\/jlb.3HI1215-542R","article-title":"Human mast cells capture, store, and release bioactive, exogenous il-17a","volume":"100","author":"Noordenbos","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.clim.2025.110645_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104136","article-title":"Dynamic trafficking patterns of IL-17-producing \u03b3\u03b4 T cells are linked to the recurrence of skin inflammation in psoriasis-like dermatitis","volume":"82","author":"Liu","year":"2022","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.clim.2025.110645_bb0135","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1007\/s00281-018-0675-z","article-title":"Skin neurogenic inflammation","volume":"40","author":"Choi","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.clim.2025.110645_bb0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41467-017-02466-4","article-title":"TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis","volume":"9","author":"Conrad","year":"2018","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.clim.2025.110645_bb0145","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.3390\/ijms25137018","article-title":"Paradoxical psoriasis in patients receiving therapy with tumor necrosis factor inhibitors: potential pathogenic mechanisms and the role of genetic factors","volume":"25","author":"Costin","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2025.110645_bb0150","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jid.2019.10.010","article-title":"Enrichment of polyfunctional IL-17-producing T cells in paradoxical psoriasis skin lesions","volume":"140","author":"Moran","year":"2020","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.clim.2025.110645_bb0155","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gutjnl-2012-302853","article-title":"Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-\u03b3-expressing Th1 cells and IL-17A\/IL-22-expressing Th17 cells and respond to anti-IL-12\/IL-23 antibody treatment","volume":"63","author":"Tillack","year":"2014","journal-title":"Gut"},{"issue":"18","key":"10.1016\/j.clim.2025.110645_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814390","article-title":"A route for investigating psoriasis: from the perspective of the pathological mechanisms and therapeutic strategies of cancer","volume":"24","author":"Wu","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625002207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625002207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:28:05Z","timestamp":1769128085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661625002207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"alternative-id":["S1521661625002207"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2025.110645","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remaining molecular scarring in the skin of patients with psoriasis: What are the reversal factors?","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2025.110645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110645"}}